A dual thrombin receptor system for platelet activation

Mark L. Kahn, Yao-Wu Zheng, Wei Huang, Violeta Bigornia, Dewan Zeng, Stephen Moff, Robert V. Farese, Carmen Tam and Shaun R. Coughlin ()
Additional contact information
Mark L. Kahn: Cardiovascular Research Institute and Daiichi Research Center
Yao-Wu Zheng: Cardiovascular Research Institute and Daiichi Research Center
Wei Huang: Cardiovascular Research Institute and Daiichi Research Center
Violeta Bigornia: Cardiovascular Research Institute and Daiichi Research Center
Dewan Zeng: Cardiovascular Research Institute and Daiichi Research Center
Stephen Moff: Cardiovascular Research Institute and Daiichi Research Center
Robert V. Farese: Department of Medicine
Carmen Tam: Cardiovascular Research Institute and Daiichi Research Center
Shaun R. Coughlin: Cardiovascular Research Institute and Daiichi Research Center

Nature, 1998, vol. 394, issue 6694, 690-694

Abstract: Abstract Platelet-dependent arterial thrombosis triggers most heart attacks and strokes. Because the coagulation protease thrombin is the most potent activator of platelets1, identification of the platelet receptors for thrombin is critical for understanding thrombosis and haemostasis. Protease-activated receptor-1 (PAR1) is important for activation of human platelets by thrombin2,3,4,5,6, but plays no apparent role in mouse platelet activation7,8,9. PAR3 is a thrombin receptor that is expressed in mouse megakaryocytes10. Here we report that thrombin responses in platelets from PAR3-deficient mice were markedly delayed and diminished but not absent. We have also identified PAR4, a new thrombin-activated receptor. PAR4 messenger RNA was detected in mouse megakaryocytes and a PAR4-activating peptide caused secretion and aggregation of PAR3-deficient mouse platelets. Thus PAR3 is necessary for normal thrombin responses in mouse platelets, but a second PAR4-mediated mechanism for thrombin signalling exists. Studies with PAR-activating peptides suggest that PAR4 also functions in human platelets, which implies that an analogous dual-receptor system also operates in humans. The identification of a two-receptor system for platelet activation by thrombin has important implications for the development of antithrombotic therapies.

Date: 1998
References: Add references at CitEc
Citations:

Downloads: (external link)
https://www.nature.com/articles/29325 Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:nature:v:394:y:1998:i:6694:d:10.1038_29325

Ordering information: This journal article can be ordered from
https://www.nature.com/

DOI: 10.1038/29325

Access Statistics for this article

Nature is currently edited by Magdalena Skipper

More articles in Nature from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().